消化内镜治疗非静脉曲张性上消化道出血后再出血危险因素分析

Abstract
Figure/Table
References (15)
Related Citation (1)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo analyze the risk factors of rebleeding of non－variceal upper gastrointestinal hemorrhage treated by gastrointestinal endoscopy.MethodsFrom February 2015 to February 2017,a total of 216 patients with non－variceal upper gastrointestinal bleeding who underwent endoscopic treatment in our hospital were selected as research objects.A-mong them,41 patients occurred with rebleeding and classified into the observation group,and the rest(n=175)without rebleeding was categorized into the control group.The basic data,examination indexes,and treatment process were recorded and compared.ResultsIn the observation group,the levels of hemoglobin and thrombocyte were both remarkably lower than those in the control group(P＜0.05).The percentage of vascular malformation,treatment time＞24 h,cardia tearing,hemorrhage of gradeⅠa,insufficiency of supportive treatment,hemorrhage due to malignant tumors and lack of following PPIs were all much higher than those in the control group (P＜0.05).Vascular malformation,Hemorrhage of gradeⅠa,cardia tearing and hemorrhage due to malignant tumors were all independent risk factors leading to rebleeding after gastrointestinal endoscopy(P＜0.01).ConclusionFor patients suffering from non－variceal upper gastrointestinal hemorrhage after gastrointestinal endoscopy,insufficiency of supportive treatment and low－level of hemochrome causes rebleeding.Besides,hemorrhage due to malignant tumor is also an important risk factor,which should be strengthened protection in time in order to ensure health of patients.

Key words： Digestive endoscopy Non－variceal upper gastrointestinal bleeding Rebleeding:Risk factors

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU Lian-hui
	LUO Jia
	LIN Ming-fang

Cite this article:

WU Lian-hui,LUO Jia,LIN Ming-fang. Risk factors analysis of rebleeding of non-variceal upper gastrointestinal hemorrhage treated by gastrointestinal endoscopy[J]. 中国当代医药, 2017, 24(29): 43-45.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I29/43

[1]	任海霞，王建华，单铁英，等.非静脉曲张性上消化道出血内镜治疗术后再出血危险因素分析[J].临床误诊误治，2016，29（8）：48－52.
[2]	袁国钧，蔡华容.非静脉曲张性上消化道出血经内镜治疗术后再出血的危险因素分析[J].海南医学院学报，2017，23（4）：482－484.
[3]	彭琼辉，王晓蕾.1417例急性非静脉曲张性上消化道出血患者再出血危险因素的分析及其临床意义[J].中华全科医学，2016，14（3）：381－383.
[4]	聂丽芬，张晓燕，黎铭恩.急性非静脉曲张性上消化道再出血患者死亡的危险因素分析[J].中国医学创新，2016，13（8）：60－63.
[5]	张建新，牛丽丹，杨亚勤，等.实验室指标联合Blatchford评分对急性上消化道出血内镜介入治疗后再出血的预测价值[J].现代消化及介入诊疗，2016，21（3）：379－382.
[6]	梁文京，符应田，黎燕锋，等.内镜下套扎联合药物注射治疗肝硬化合并上消化道出血的疗效[J].实用医学杂志，2016，32（12）：2017－2019.
[7]	叶营，孙相钊，蔡春调，等.内镜联合药物诊治肝硬化食管胃底静脉曲张破裂出血的疗效及再出血危险因素研究[J].海南医学，2017，28（3）：374－378.
[8]	金雪琴，吴兵，陈丽芬，等.急诊内镜治疗非静脉曲张性上消化道出血临床疗效分析[J].浙江临床医学，2017，19（4）：701－702.
[9]	卜玲玲，吴菁.内镜下治疗急性非静脉曲张性上消化道出血的临床效果[J].检验医学与临床，2016，13（24）：3512－3514.
[10]	徐元华.急性非静脉曲张性上消化道出血内镜介入治疗的临床效果分析[J].养生保健指南（医药研究），2017，30（1）：16.
[11]	王成，金瑞，张霞.内镜下钛夹治疗非静脉曲张性上消化道出血临床观察[J].陕西医学杂志，2016，45（10）：1325－1326.
[12]	邹开亮.内镜下治疗非静脉曲张性上消化道出血98例疗效分析[J].江苏医药，2015，41（9）：1036－1038.
[13]	张华宝，许健瑞，陈波.急诊非静脉曲张性上消化道出血内镜诊治时间延长的相关因素分析[J].现代消化及介入诊疗，2016，21（3）：460－462.
[14]	张梅.非静脉曲张性消化道出血内镜下治疗的临床效果[J].中国现代药物应用，2016，10（12）：65－66.
[15]	郭宗全，李艳梅，陈新华，等.上消化道出血的病因分析及对诊疗工作的启示[J].现代消化及介入诊疗，2016，21（1）：87－89.